Aneusomy and tumor heterogeneity in metastatic breast cancer detected by fluorescence in situ hybridization

被引:0
|
作者
Cianciulli, AM
Pescatore, B
Venturo, I
Greco, C
Lopez, M
Gandolfo, GM
机构
[1] NATL CANC INST,DEPT CLIN PATHOL,ROME,ITALY
[2] NATL CANC INST,DEPT MED ONCOL,ROME,ITALY
关键词
breast cancer; aneusomy; fluorescent in situ hybridization;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Direct interphase cytogenetic analysis was performed on nuclei of metastatic effusions from breast cancer using fluorescence ill situ hybridization (FISH). DNA probes specific for repetitive pericentromeric regions on chromosomes 6, 8, 17, and human midi-satellite probe specific for one locus on the short arm of chromosome 1 were used to determine chromosome copy numbers in interphase tumor cells. The analysis showed cytogenetic heterogeneity in most nuclei examined with multiple subpopulations and a range of 0-6 chromosome signals per cell. The presence of subclones in these fluids, their correlation with highly malignant phenotypes and the diagnostic and prognostic applications of this method is discussed.
引用
收藏
页码:1039 / 1042
页数:4
相关论文
共 50 条
  • [31] Detection of chromosomal aneusomy by fluorescence in situ hybridization in fine-needle aspirates from breast tumors: Application to the preoperative diagnosis of breast carcinoma
    Tsukamoto, F
    Miyoshi, Y
    Koyama, H
    Watatani, M
    Sasa, M
    Shiba, E
    Takami, S
    Inazawa, J
    Noguchi, S
    CANCER CYTOPATHOLOGY, 2000, 90 (06): : 373 - 378
  • [32] Comparison of HER-2/neu oncogene amplification detected by fluorescence in situ hybridization in lobular and ductal breast cancer
    Rosenthal, SI
    Depowski, PL
    Sheehan, CE
    Ross, JS
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2002, 10 (01): : 40 - 46
  • [33] Understanding and overcoming tumor heterogeneity in metastatic breast cancer treatment
    Nida Pasha
    Nicholas C. Turner
    Nature Cancer, 2021, 2 : 680 - 692
  • [34] Understanding and overcoming tumor heterogeneity in metastatic breast cancer treatment
    Pasha, Nida
    Turner, Nicholas C.
    NATURE CANCER, 2021, 2 (07) : 680 - 692
  • [35] Chromosomal alterations in breast cancer revealed by multicolour fluorescence in situ hybridization
    Watson, MB
    Bahia, H
    Ashman, JNE
    Berrieman, HK
    Drew, P
    Lind, MJ
    Greenman, J
    Cawkwell, L
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2004, 25 (02) : 277 - 283
  • [36] Evaluation of Intratumoral HER-2 Heterogeneity by Fluorescence In Situ Hybridization in Invasive Breast Cancer: A Single Institution Study
    Lee, Sarah
    Jung, Woohee
    Hong, SoonWon
    Koo, Ja Seung
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2011, 26 (08) : 1001 - 1006
  • [37] Evaluation of Genetic Status of HER-2/neu and Aneusomy 17 by Fluorescence In Situ Hybridization and Comparison with Immunohistochemistry Assay from Indian Breast Cancer Patients
    Kokate, Prajakta
    Sawaimoon, Satyakam
    Bhatia, Simi
    Mandava, Swarna
    GENETIC TESTING AND MOLECULAR BIOMARKERS, 2012, 16 (04) : 239 - 245
  • [38] THE NUMERICAL ABERRATIONS OF CHROMOSOME 7 DETECTED BY FLUORESCENCE IN-SITU HYBRIDIZATION IN HUMAN BREAST CANCERS
    YOSHIMI, N
    SHIBUYA, C
    MORISHITA, Y
    TANAKA, T
    MORI, H
    ACTA PATHOLOGICA JAPONICA, 1993, 43 (12): : 730 - 735
  • [39] HER2 positivity in breast carcinoma: A comparison of chromogenic in situ hybridization with fluorescence in situ hybridization in tissue microarrays, with targeted evaluation of intratumoral heterogeneity by in situ hybridization
    Loring, P
    Cummins, R
    O'Grady, A
    Kay, EW
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2005, 13 (02) : 194 - 200
  • [40] Aberrations of chromosomes 9 and 17 in bilharzial bladder cancer as detected by fluorescence in situ hybridization
    Ghaleb, AH
    Pizzolo, JG
    Melamed, MR
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1996, 106 (02) : 234 - 241